Copyright Reports & Markets. All rights reserved.

Global Muscle Relaxant Drugs Market Research Report 2019

Request for Sample of this report
Buy now

Table of Contents

    Executive Summary

      1 Muscle Relaxant Drugs Market Overview

      • 1.1 Product Overview and Scope of Muscle Relaxant Drugs
      • 1.2 Muscle Relaxant Drugs Segment by Type
        • 1.2.1 Global Muscle Relaxant Drugs Production Growth Rate Comparison by Type (2014-2025)
        • 1.2.2 Skeletal Muscle Relaxant Drugs
        • 1.2.3 Facial Muscle Relaxant Drugs
      • 1.3 Muscle Relaxant Drugs Segment by Application
        • 1.3.1 Muscle Relaxant Drugs Consumption Comparison by Application (2014-2025)
        • 1.3.2 Hospital Pharmacies
        • 1.3.3 Retail Pharmacies
        • 1.3.4 Others
      • 1.4 Global Muscle Relaxant Drugs Market by Region
        • 1.4.1 Global Muscle Relaxant Drugs Market Size Region
        • 1.4.2 North America Status and Prospect (2014-2025)
        • 1.4.3 Europe Status and Prospect (2014-2025)
        • 1.4.4 China Status and Prospect (2014-2025)
        • 1.4.5 Japan Status and Prospect (2014-2025)
      • 1.5 Global Muscle Relaxant Drugs Market Size
        • 1.5.1 Global Muscle Relaxant Drugs Revenue (2014-2025)
        • 1.5.2 Global Muscle Relaxant Drugs Production (2014-2025)

      2 Global Muscle Relaxant Drugs Market Competition by Manufacturers

      • 2.1 Global Muscle Relaxant Drugs Production Market Share by Manufacturers (2014-2019)
      • 2.2 Global Muscle Relaxant Drugs Revenue Share by Manufacturers (2014-2019)
      • 2.3 Global Muscle Relaxant Drugs Average Price by Manufacturers (2014-2019)
      • 2.4 Manufacturers Muscle Relaxant Drugs Production Sites, Area Served, Product Types
      • 2.5 Muscle Relaxant Drugs Market Competitive Situation and Trends
        • 2.5.1 Muscle Relaxant Drugs Market Concentration Rate
        • 2.5.2 Muscle Relaxant Drugs Market Share of Top 3 and Top 5 Manufacturers
        • 2.5.3 Mergers & Acquisitions, Expansion

      3 Global Muscle Relaxant Drugs Production Market Share by Regions

      • 3.1 Global Muscle Relaxant Drugs Production Market Share by Regions
      • 3.2 Global Muscle Relaxant Drugs Revenue Market Share by Regions (2014-2019)
      • 3.3 Global Muscle Relaxant Drugs Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.4 North America Muscle Relaxant Drugs Production
        • 3.4.1 North America Muscle Relaxant Drugs Production Growth Rate (2014-2019)
        • 3.4.2 North America Muscle Relaxant Drugs Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.5 Europe Muscle Relaxant Drugs Production
        • 3.5.1 Europe Muscle Relaxant Drugs Production Growth Rate (2014-2019)
        • 3.5.2 Europe Muscle Relaxant Drugs Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.6 China Muscle Relaxant Drugs Production (2014-2019)
        • 3.6.1 China Muscle Relaxant Drugs Production Growth Rate (2014-2019)
        • 3.6.2 China Muscle Relaxant Drugs Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.7 Japan Muscle Relaxant Drugs Production (2014-2019)
        • 3.7.1 Japan Muscle Relaxant Drugs Production Growth Rate (2014-2019)
        • 3.7.2 Japan Muscle Relaxant Drugs Production, Revenue, Price and Gross Margin (2014-2019)

      4 Global Muscle Relaxant Drugs Consumption by Regions

      • 4.1 Global Muscle Relaxant Drugs Consumption by Regions
      • 4.2 North America Muscle Relaxant Drugs Consumption (2014-2019)
      • 4.3 Europe Muscle Relaxant Drugs Consumption (2014-2019)
      • 4.4 China Muscle Relaxant Drugs Consumption (2014-2019)
      • 4.5 Japan Muscle Relaxant Drugs Consumption (2014-2019)

      5 Global Muscle Relaxant Drugs Production, Revenue, Price Trend by Type

      • 5.1 Global Muscle Relaxant Drugs Production Market Share by Type (2014-2019)
      • 5.2 Global Muscle Relaxant Drugs Revenue Market Share by Type (2014-2019)
      • 5.3 Global Muscle Relaxant Drugs Price by Type (2014-2019)
      • 5.4 Global Muscle Relaxant Drugs Production Growth by Type (2014-2019)

      6 Global Muscle Relaxant Drugs Market Analysis by Applications

      • 6.1 Global Muscle Relaxant Drugs Consumption Market Share by Application (2014-2019)
      • 6.2 Global Muscle Relaxant Drugs Consumption Growth Rate by Application (2014-2019)

      7 Company Profiles and Key Figures in Muscle Relaxant Drugs Business

      • 7.1 Pfizer
        • 7.1.1 Pfizer Muscle Relaxant Drugs Production Sites and Area Served
        • 7.1.2 Muscle Relaxant Drugs Product Introduction, Application and Specification
        • 7.1.3 Pfizer Muscle Relaxant Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.1.4 Main Business and Markets Served
      • 7.2 Allergan
        • 7.2.1 Allergan Muscle Relaxant Drugs Production Sites and Area Served
        • 7.2.2 Muscle Relaxant Drugs Product Introduction, Application and Specification
        • 7.2.3 Allergan Muscle Relaxant Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.2.4 Main Business and Markets Served
      • 7.3 Ipsen Group
        • 7.3.1 Ipsen Group Muscle Relaxant Drugs Production Sites and Area Served
        • 7.3.2 Muscle Relaxant Drugs Product Introduction, Application and Specification
        • 7.3.3 Ipsen Group Muscle Relaxant Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.3.4 Main Business and Markets Served
      • 7.4 Teva Pharmaceuticals
        • 7.4.1 Teva Pharmaceuticals Muscle Relaxant Drugs Production Sites and Area Served
        • 7.4.2 Muscle Relaxant Drugs Product Introduction, Application and Specification
        • 7.4.3 Teva Pharmaceuticals Muscle Relaxant Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.4.4 Main Business and Markets Served
      • 7.5 Novartis
        • 7.5.1 Novartis Muscle Relaxant Drugs Production Sites and Area Served
        • 7.5.2 Muscle Relaxant Drugs Product Introduction, Application and Specification
        • 7.5.3 Novartis Muscle Relaxant Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.5.4 Main Business and Markets Served
      • 7.6 Johnson & Johnson
        • 7.6.1 Johnson & Johnson Muscle Relaxant Drugs Production Sites and Area Served
        • 7.6.2 Muscle Relaxant Drugs Product Introduction, Application and Specification
        • 7.6.3 Johnson & Johnson Muscle Relaxant Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.6.4 Main Business and Markets Served
      • 7.7 Takeda Pharmaceutical
        • 7.7.1 Takeda Pharmaceutical Muscle Relaxant Drugs Production Sites and Area Served
        • 7.7.2 Muscle Relaxant Drugs Product Introduction, Application and Specification
        • 7.7.3 Takeda Pharmaceutical Muscle Relaxant Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.7.4 Main Business and Markets Served
      • 7.8 Sun Pharmaceutical
        • 7.8.1 Sun Pharmaceutical Muscle Relaxant Drugs Production Sites and Area Served
        • 7.8.2 Muscle Relaxant Drugs Product Introduction, Application and Specification
        • 7.8.3 Sun Pharmaceutical Muscle Relaxant Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.8.4 Main Business and Markets Served
      • 7.9 Merz Pharma
        • 7.9.1 Merz Pharma Muscle Relaxant Drugs Production Sites and Area Served
        • 7.9.2 Muscle Relaxant Drugs Product Introduction, Application and Specification
        • 7.9.3 Merz Pharma Muscle Relaxant Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.9.4 Main Business and Markets Served
      • 7.10 Mylan
        • 7.10.1 Mylan Muscle Relaxant Drugs Production Sites and Area Served
        • 7.10.2 Muscle Relaxant Drugs Product Introduction, Application and Specification
        • 7.10.3 Mylan Muscle Relaxant Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.10.4 Main Business and Markets Served
      • 7.11 Fresenius Kabi
      • 7.12 Endo International
      • 7.13 Par Sterile Products
      • 7.14 Acorda Therapeutics
      • 7.15 SteriMax Inc
      • 7.16 Emcure Pharmaceuticals
      • 7.17 Upsher-Smith Laboratories
      • 7.18 Orient Pharma
      • 7.19 Daewoong Pharmaceutical

      8 Muscle Relaxant Drugs Manufacturing Cost Analysis

      • 8.1 Muscle Relaxant Drugs Key Raw Materials Analysis
        • 8.1.1 Key Raw Materials
        • 8.1.2 Price Trend of Key Raw Materials
        • 8.1.3 Key Suppliers of Raw Materials
      • 8.2 Proportion of Manufacturing Cost Structure
      • 8.3 Manufacturing Process Analysis of Muscle Relaxant Drugs
      • 8.4 Muscle Relaxant Drugs Industrial Chain Analysis

      9 Marketing Channel, Distributors and Customers

      • 9.1 Marketing Channel
        • 9.1.1 Direct Marketing
        • 9.1.2 Indirect Marketing
      • 9.2 Muscle Relaxant Drugs Distributors List
      • 9.3 Muscle Relaxant Drugs Customers

      10 Market Dynamics

      • 10.1 Market Trends
      • 10.2 Opportunities
      • 10.3 Market Drivers
      • 10.4 Challenges
      • 10.5 Influence Factors

      11 Global Muscle Relaxant Drugs Market Forecast

      • 11.1 Global Muscle Relaxant Drugs Production, Revenue Forecast
        • 11.1.1 Global Muscle Relaxant Drugs Production Growth Rate Forecast (2019-2025)
        • 11.1.2 Global Muscle Relaxant Drugs Revenue and Growth Rate Forecast (2019-2025)
        • 11.1.3 Global Muscle Relaxant Drugs Price and Trend Forecast (2019-2025)
      • 11.2 Global Muscle Relaxant Drugs Production Forecast by Regions (2019-2025)
        • 11.2.1 North America Muscle Relaxant Drugs Production, Revenue Forecast (2019-2025)
        • 11.2.2 Europe Muscle Relaxant Drugs Production, Revenue Forecast (2019-2025)
        • 11.2.3 China Muscle Relaxant Drugs Production, Revenue Forecast (2019-2025)
        • 11.2.4 Japan Muscle Relaxant Drugs Production, Revenue Forecast (2019-2025)
      • 11.3 Global Muscle Relaxant Drugs Consumption Forecast by Regions (2019-2025)
        • 11.3.1 North America Muscle Relaxant Drugs Consumption Forecast (2019-2025)
        • 11.3.2 Europe Muscle Relaxant Drugs Consumption Forecast (2019-2025)
        • 11.3.3 China Muscle Relaxant Drugs Consumption Forecast (2019-2025)
        • 11.3.4 Japan Muscle Relaxant Drugs Consumption Forecast (2019-2025)
      • 11.4 Global Muscle Relaxant Drugs Production, Revenue and Price Forecast by Type (2019-2025)
      • 11.5 Global Muscle Relaxant Drugs Consumption Forecast by Application (2019-2025)

      12 Research Findings and Conclusion

        13 Methodology and Data Source

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        Muscle spasticity is caused by damage to the spinal cord or brain. Nerves in the brain and spinal cord help relax the muscles during the idle state. Conditions that affect the brain or spinal cord such as multiple sclerosis, cerebral palsy, and stroke can interfere with normal muscle relaxation, leading to involuntary muscle spasms. This will impair the ability to walk, work, sleep, or just function normally. The muscles can also become excessively tense and develop overactive or overresponsive reflexes. Severe cases can lead to deep disability, including an inability to straighten out joints. Muscle relaxant drugs are primarily used in conjunction with general anesthetics to achieve muscle relaxation during surgical interventions.
        Old age is associated with the loss of fibrous tissue, and reduced vascular and glandular network in the layers of skin. In the elderly population, the appearance and characteristics of the skin gets altered, leading to wrinkles, appearance of frown lines, dryness, pigmentary alteration, and sagging of the skin. Muscle relaxant-based procedures help in reducing skin aging, thus giving younger look to a person by revitalizing and tightening the skin.

        The global Muscle Relaxant Drugs market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
        This report focuses on Muscle Relaxant Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall Muscle Relaxant Drugs market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
        At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

        The following manufacturers are covered:
        Pfizer
        Allergan
        Ipsen Group
        Teva Pharmaceuticals
        Novartis
        Johnson & Johnson
        Takeda Pharmaceutical
        Sun Pharmaceutical
        Merz Pharma
        Mylan
        Fresenius Kabi
        Endo International
        Par Sterile Products
        Acorda Therapeutics
        SteriMax Inc
        Emcure Pharmaceuticals
        Upsher-Smith Laboratories
        Orient Pharma
        Daewoong Pharmaceutical

        Segment by Regions
        North America
        Europe
        China
        Japan

        Segment by Type
        Skeletal Muscle Relaxant Drugs
        Facial Muscle Relaxant Drugs

        Segment by Application
        Hospital Pharmacies
        Retail Pharmacies
        Others

        Buy now